This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03587/identifier/chebi/
n4http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03587/identifier/pdb/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/resource/drugbank/drug/DB03587/identifier/pubchem-compound/
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n9http://linked.opendata.cz/resource/drugbank/drug/DB03587/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03587/identifier/drugbank/

Statements

Subject Item
n2:DB03587
rdf:type
n5:Drug
n5:description
An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals. [PubChem]
n5:group
experimental
owl:sameAs
n4:DB03587 n13:DB03587
dcterms:title
Pyruvoyl Group
adms:identifier
n8:880 n9:46509036 n11:DB03587 n12:PVL n14:45360
n5:IUPAC-Name
n6:271B5648-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B564E-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B564D-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B564A-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B564B-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B564C-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5646-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5647-363D-11E5-9242-09173F13E4C5 n6:271B5644-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5645-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5654-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5655-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B564F-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5650-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5652-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5651-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5653-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B565A-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B565C-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B565D-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5659-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5658-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B565B-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5649-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5656-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5657-363D-11E5-9242-09173F13E4C5